Korea News
-
Japan's Toray rolls out Remitch tablets for Pruritus treatment in Korea
Korea | News | 0 Comment | 17 Jan, 2023
Japan-based Toray Industries, Inc., has announced that Korean marketing partner SK Chemicals Co. has begun selling REMIT...Read more
-
New partnerships in Korea to transform mRNA technology into more vaccines
Korea | News | 0 Comment | 16 Jan, 2023
Gachon University, the Korea mRNA Vaccine Initiative (KmVAC), and the International Vaccine Institute (IVI) recently exc...Read more
-
Korea | News | 0 Comment | 13 Jan, 2023
Celltrion Healthcare, a South Korean biopharmaceutical company specialising in the development and production of biosimi...Read more
-
Southern Star Research announces expansion into South Korea and Singapore
Korea | News | 1 Comment | 12 Jan, 2023
Southern Star Research, an Australian contract research organisation (CRO) specialising in clinical trial acceleration w...Read more
-
IVI, Batavia Biosciences sign MoU for vaccine research and development
Korea | News | 0 Comment | 10 Jan, 2023
The International Vaccine Institute (IVI), a South Korea-based international organisation devoted to vaccines for global...Read more
-
Lunit provides AI-based chest X-Ray solution to Latin America's largest hospital
Korea | News | 0 Comment | 09 Jan, 2023
South Korea-based startup Lunit has signed a software license agreement with the Hospital Israelita Albert Einstein in S...Read more
-
South Korea's Alteogen partners with Sandoz AG for biosimilars
Korea | News | 0 Comment | 04 Jan, 2023
South Korean firm Alteogen Inc has entered into an exclusive license agreement with Sandoz AG. Under the terms of t...Read more
-
Korea | News | 0 Comment | 30 Dec, 2022
South Korea-based LifeSemantics has launched Redpill Breath, a digital therapeutics (DTx) for patients requiri...Read more
-
South Korea's EOFlow takes wearable insulin patch to US market
Korea | News | 0 Comment | 28 Dec, 2022
EOFlow, a provider of wearable drug delivery systems (DDS), has announced that it has submitted a 510(k) application to ...Read more
-
Korean firm LegoChem Biosciences inks $1.25 B research collaboration with Amgen
Korea | News | 0 Comment | 26 Dec, 2022
South Korea-based LegoChem Biosciences, Inc. (LCB) has entered into a research collaboration and license agree...Read more
-
Korea's Amorepacific inks beauty research agreement with Johns Hopkins University
Korea | News | 0 Comment | 21 Dec, 2022
Amorepacific Corporation, a South Korean beauty and cosmetics conglomerate, has announced its successful execution of a ...Read more
-
Researchers at Australia & Korea investigate effect of COVID-19 virus on vision
Korea | News | 0 Comment | 20 Dec, 2022
A study, co-led by Australia-based Griffith University’s Menzies Health Institute and South Korea’s Center f...Read more
-
Korea designs Myocardial Infarction treatment patch
Korea | News | 0 Comment | 19 Dec, 2022
Myocardial infarction is an ischemic disease in which a coronary artery supplying blood to the heart muscle is stenotic ...Read more
-
Korea, Singapore strengthen bilateral cooperation over digital health medical devices
Korea | News | 0 Comment | 16 Dec, 2022
South Korean Ministry of Food and Drug Safety (MFDS) recently held a bilateral meeting with Health Sciences Authori...Read more
-
SK Biopharma unveils vision for digital healthcare in Korea
Korea | News | 0 Comment | 14 Dec, 2022
South Korea-based SK Biopharmaceuticals has introduced its roadmap and vision for its digital healthcare business. ...Read more
-
US promotes networking and investment for Korean medical startups
Korea | News | 0 Comment | 12 Dec, 2022
Over the past several months, the Korean Startup Center (KSC) Seattle and IntuitiveX (IX), in partnership with...Read more
-
Korea convened ROK-ASEAN invitational meeting for enhancing cooperation in healthcare
Korea | News | 0 Comment | 08 Dec, 2022
The Ministry of Health and Welfare and the Korea Health Promotion Institute held a ROK-ASEAN In...Read more
-
Korea's Daewoong Pharma aims to bring new diabetes drug in over 50 countries by 2030
Korea | News | 0 Comment | 08 Dec, 2022
South Korea-based Daewoong Pharmaceutical's "Envlo 0.3mg", a new sodium-glucose cotransporters 2 inhibitor (SGLT2) devel...Read more
